AXM (Pink Sheets: AXMP) is the parent company of AXM Shenyang. The company was founded in 2004 at Shenyang, China. Its mission is to become a premier China-based US GMP pharmaceutical manufacturer and distributor targeting and penetrating the markets of China. The company currently owns licenses and is capable to produce both prescription and nonprescription drugs. AXM Shenyang has the ability to produce 30,000,000 tubes for ointment, 500,000,000 tablets and 250,000,000 capsules annually. The company has six buildings totaling over 200,000 square feet that are built on more than 13 acres of campus. It has the technology of microbial fermentation which is used to produce testosaterone and testosaterone undecanoate. In 2007, AXM Shenyang was appointed to sell GM1 as exclusive distributor for Brazil. Currently AXM Shenyang has more than 200 people in marketing and distribution serving more than 20 provinces in China. http://www.cordblood-america.com/cbai-news/129-china-cord-blood-america-otc-bb-cbai-to-operate-stem-cell-business
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.